A Score of Low-Grade Inflammation for Predicting Stroke Recurrence in Patients with Ischemic Stroke

References

• Wang YJ, Li ZX, Gu HQ, et al. China Stroke Statistics 2019: a report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations. Stroke Vasc Neurol. 2020;5:211–239.
   PubMedGoogle Scholar
• Krishnamurthi RV, Feigin VL, Forouzanfar MH, et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet Glob Health. 2013;1:e259–281. doi:10.1016/S2214-109X(13)70089-5
   PubMed Web of Science ®Google Scholar
• Mohan KM, Crichton SL, Grieve AP, Rudd AG, Wolfe CD, Heuschmann PU. Frequency and predictors for the risk of stroke recurrence up to 10 years after stroke: the South London Stroke Register. J Neurol Neurosurg Psychiatry. 2009;80:1012–1018. doi:10.1136/jnnp.2008.170456
   PubMed Web of Science ®Google Scholar
• Flach C, Muruet W, Wolfe CDA, Bhalla A, Douiri A. Risk and secondary prevention of stroke recurrence: a population-base cohort study. Stroke. 2020;51:2435–2444. doi:10.1161/STROKEAHA.120.028992
   PubMed Web of Science ®Google Scholar
• Liu X, Xu G, Wu W, Zhang R, Yin Q, Zhu W. Subtypes and one-year survival of first-ever stroke in Chinese patients: the Nanjing Stroke Registry. Cerebrovasc Dis. 2006;22:130–136. doi:10.1159/000093241
   PubMed Web of Science ®Google Scholar
• van Wijk I, Kappelle LJ, van Gijn J, et al. Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study. Lancet. 2005;365(9477):2098–2104. doi:10.1016/S0140-6736(05)66734-7
   PubMed Web of Science ®Google Scholar
• Engström G, Hedblad B, Stavenow L, et al. Incidence of obesity-associated cardiovascular disease is related to inflammation-sensitive plasma proteins: a population-based cohort study. Arterioscler Thromb Vasc Biol. 2004;24:1498–1502. doi:10.1161/01.ATV.0000134293.31512.be
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860–867. doi:10.1038/nature01322
   PubMed Web of Science ®Google Scholar
• Samuels MA. Inflammation and neurological disease. Curr Opin Neurol. 2004;17:307–309. doi:10.1097/00019052-200406000-00012
   PubMed Web of Science ®Google Scholar
• Barbaresko J, Koch M, Schulze MB, Nöthlings U. Dietary pattern analysis and biomarkers of low-grade inflammation: a systematic literature review. Nutr Rev. 2013;71:511–527. doi:10.1111/nure.12035
   PubMed Web of Science ®Google Scholar
• Bonaccio M, Di Castelnuovo A, Pounis G, et al. A score of low-grade inflammation and risk of mortality: prospective findings from the Moli-sani study. Haematologica. 2016;101:1434–1441. doi:10.3324/haematol.2016.144055
   PubMed Web of Science ®Google Scholar
• Danesh J, Whincup P, Walker M, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ. 2000;321:199–204. doi:10.1136/bmj.321.7255.199
   PubMed Web of Science ®Google Scholar
• Grau AJ, Boddy AW, Dukovic DA, et al. Leukocyte count as an independent predictor of recurrent ischemic events. Stroke. 2004;35:1147–1152. doi:10.1161/01.STR.0000124122.71702.64
   PubMed Web of Science ®Google Scholar
• Kuwashiro T, Sugimori H, Ago T, Kuroda J, Kamouchi M, Kitazono T. Predictive role of C reactive protein in stroke recurrence after cardioembolic stroke: the Fukuoka Stroke Registry. BMJ Open. 2013;3:e003678. doi:10.1136/bmjopen-2013-003678
   PubMed Web of Science ®Google Scholar
• Castillo J, Alvarez-Sabín J, Martínez-Vila E, Montaner J, Sobrino T, Vivancos J. Inflammation markers and prediction of post-stroke vascular disease recurrence: the MITICO study. J Neurol. 2009;256:217–224. doi:10.1007/s00415-009-0058-4
   PubMed Web of Science ®Google Scholar
• Kim S, Eliot M, Koestler DC, Wu WC, Kelsey KT. Association of neutrophil-to-lymphocyte ratio with mortality and cardiovascular disease in the Jackson heart study and modification by the Duffy antigen variant. JAMA Cardiol. 2018;3:455–462. doi:10.1001/jamacardio.2018.1042
   PubMed Web of Science ®Google Scholar
• Xu G, Liu X, Wu W, Zhang R, Yin Q. Recurrence after ischemic stroke in Chinese patients: impact of uncontrolled modifiable risk factors. Cerebrovasc Dis. 2007;23:117–120. doi:10.1159/000097047
   PubMed Web of Science ®Google Scholar
• Goldstein LB, Samsa GP. Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial. Stroke. 1997;28:307–310.
   PubMed Web of Science ®Google Scholar
• Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35–41. doi:10.1161/01.STR.24.1.35
   PubMed Web of Science ®Google Scholar
• Ramanujam R, Hedstrom AK, Manouchehrinia A, et al. Effect of smoking cessation on multiple sclerosis prognosis. JAMA Neurol. 2015;72:1117–1123. doi:10.1001/jamaneurol.2015.1788
   PubMed Web of Science ®Google Scholar
• Chen J, Li S, Zheng K, et al. Impact of smoking status on stroke recurrence. J Am Heart Assoc. 2019;8:e011696. doi:10.1161/JAHA.118.011696
   PubMed Web of Science ®Google Scholar
• Stroke. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders. Stroke. 1989;20:1407–1431. doi:10.1161/01.STR.20.10.1407
   PubMed Web of Science ®Google Scholar
• Geskus RB. Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring. Biometrics. 2011;67:39–49. doi:10.1111/j.1541-0420.2010.01420.x
   PubMed Web of Science ®Google Scholar
• Oza R, Rundell K, Garcellano M. Recurrent ischemic stroke: strategies for prevention. Am Fam Physician. 2017;96:436–440.
   PubMed Web of Science ®Google Scholar
• Welsh P, Lowe GDO, Chalmers J, et al. Associations of proinflammatory cytokines with the risk of recurrent stroke. Stroke. 2008;39:2226–2230. doi:10.1161/STROKEAHA.107.504498
   PubMed Web of Science ®Google Scholar
• Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest. 2005;115:3378–3384. doi:10.1172/JCI27196
   PubMed Web of Science ®Google Scholar
• Di Napoli M, Papa F. Systemic inflammation, blood pressure, and stroke outcome. J Clin Hypertens. 2006;8:187–194. doi:10.1111/j.1524-6175.2005.04590.x
   Google Scholar
• Zhou X, Yu F, Feng X, et al. Immunity and inflammation predictors for short-term outcome of stroke in young adults. Int J Neurosci. 2018;128:634–639. doi:10.1080/00207454.2017.1408614
   PubMed Web of Science ®Google Scholar
• Zhang XG, Xue J, Yang WH, et al. Inflammatory markers as independent predictors for stroke outcomes. Brain Behav. 2021;11:e01922. doi:10.1002/brb3.1922
   PubMed Web of Science ®Google Scholar
• Pennlert J, Asplund K, Glader EL, Norrving B, Eriksson M. Socioeconomic status and the risk of stroke recurrence: persisting gaps observed in a nationwide Swedish study 2001 to 2012. Stroke. 2017;48:1518–1523. doi:10.1161/STROKEAHA.116.015643
   PubMed Web of Science ®Google Scholar
• Sjölander M, Eriksson M, Glader EL. Social stratification in the dissemination of statins after stroke in Sweden. Eur J Clin Pharmacol. 2013;69:1173–1180. doi:10.1007/s00228-012-1454-8
   PubMed Web of Science ®Google Scholar
• Sjölander M, Eriksson M, Asplund K, Norrving B, Glader EL. Socioeconomic inequalities in the prescription of oral anticoagulants in stroke patients with atrial fibrillation. Stroke. 2015;46:2220–2225. doi:10.1161/STROKEAHA.115.009718
   PubMed Web of Science ®Google Scholar
• Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation. 2001;103:1194–1197. doi:10.1161/01.CIR.103.9.1194
   PubMed Web of Science ®Google Scholar
• Lagrand WK, Visser CA, Hermens WT, et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation. 1999;100:96–102.
   PubMed Web of Science ®Google Scholar
• Xue J, Huang W, Chen X, et al. Neutrophil-to-lymphocyte ratio is a prognostic marker in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2017;26:650–657. doi:10.1016/j.jstrokecerebrovasdis.2016.11.010
   PubMed Web of Science ®Google Scholar